HomeTrialNCT07404865
🔬NCT07404865Phase 3RECRUITING

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Study Summary

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment250 participants
Primary Completion
Lead SponsorVor Biopharma
Data Retrieved2026-04-11 04:31:09.587484+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.